# OXACILLIN SODIUM
> **ANDA207148** · Abbreviated New Drug Application (Generic) · Sponsor: WOCKHARDT BIO AG · Approved 2017-11-24
## Drug
- **FDA Application Number:** ANDA207148
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXACILLIN SODIUM
- **Generic name:** OXACILLIN
- **Active ingredients:** OXACILLIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** WOCKHARDT BIO AG
- **Manufacturer:** Wockhardt USA LLC.
- **First approval:** 2017-11-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207148)
---
*AI Analytics · CC0 1.0*